Matthews Judith M. has filed 4 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 100000 shares of Iterum Therapeutics plc ($ITRM) on March 31, 2023.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2023 | Iterum Therapeutics plc | $ITRM | Matthews Judith M. | Chief Financial Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 12,236,607 | 9999.99% | 0.82% |
| March 11, 2023 | Iterum Therapeutics plc | $ITRM | Matthews Judith M. | Chief Financial Officer | A | Ordinary Shares | 6666 | $0.00 | 11,018.0000 | 12,236,607 | 153.17% | 0.05% |
| March 11, 2023 | Iterum Therapeutics plc | $ITRM | Matthews Judith M. | Chief Financial Officer | F | Ordinary Shares | 2883 | $0.96 | 8,135.0000 | 12,236,607 | 26.17% | 0.02% |
| March 11, 2023 | Iterum Therapeutics plc | $ITRM | Matthews Judith M. | Chief Financial Officer | M | Restricted Share Units | 6666 | $0.00 | 0.0000 | 12,236,607 | 100.00% | 0.05% |